Companies
Medtronic
Medical devicesGalway, IrelandMDTOver 95,000 employees
More about Medtronic
Medical device company that makes cardiac, neurological, surgical and diabetes devices used by hospitals and patients worldwide.
Revenue
$36.4B
Fiscal 2026 (ended April), up about 8%
Employees
Over 95,000
As of April 2026, full-time
Stock
MDT
New York Stock Exchange
Headquarters
Galway, Ireland
Principal executive offices per fiscal 2026 10-K
CEO
Geoff Martha
Since April 2020, chairman since December 2020
Main businessesCardiovascular, Neuroscience, Medical Surgical; majority stake in MiniMed (diabetes)
Current strategySeparating its diabetes business into MiniMed, which held its IPO in March 2026, and focusing on innovation-driven growth in cardiovascular, neuroscience and surgical devices
Recent workforce changesRestructuring approved in December 2025 tied to the MiniMed separation, with $300M to $500M in expected charges and $136M in employee termination costs in fiscal 2026
CompetitorsAbbott, Boston Scientific, Stryker
Related companiesAbbottBoston ScientificStryker
Checked October 11, 2026 · Sources: sec.gov
Be the first to post about Medtronic
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow Medtronic to see the first post in your watchlist.
Follow Medtronic in a feed reader, no account needed: RSS feed